Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma

This study will compare an asthma inhaler that uses a new climate friendly alternative propellant to an asthma inhaler with an existing propellant. We want to make sure both versions of the inhaler work the same way for people with mild to moderate asthma.

NCT Number	NCT07301736
Lead Sponsor	Chiesi Farmaceutici S.p.A.
Conditions	Asthma
Enrollment	780 participants
Start Date	2025-12-17
Primary Completion	2027-06-03 (estimated)
Study Completion	2027-06-03 (estimated)
Updated on ClinicalTrials.gov	2026-06-25